1718 J . Org. Chem., Vol. 65, No. 6, 2000
Sudau et al.
ane/EtOAc 3:1, Rf ) 0.25). Yield: indolizidinone 9b (90.5 mg,
127.9, 127.6, 126.5, 74.9 (d), 72.8 (t), 68.8 (d), 61.3 (d), 53.2
(t), 41.9 (t), 40.4 (d), 36.9 (t), 25.7 (q), 17.9 (s), -4.9 (q). IR
(KBr) 2927 (s), 2855 (s), 1654 (s, CO), 1258 (m) cm-1. MS (80
eV, EI, 170 °C) m/z 531(1.3) [M+], 516 (3) [M+ - CH3], 474
(40.2) [M+ - C4H9], 425 (90.1) [M+ - CH3 - C7H7], 374 (13.5)
[M+ - SePh]. HRMS calcd for C27H37NO3Si80Se: 531.17079
(M+), found 531.17552 (M+).
72%) as colorless crystals, mp 73 °C. [R]20 52.7 (c ) 1.8,
D
CHCl3). 1H NMR (270 MHz, CDCl3) δ 7.40-7.20 (m, 5 H),
4.46-4.37 (m, 1 H), 4.04-3.93 (ddd, J ) 12, 10, 3 Hz, 1 H),
3.91-3.81 (ddd, J ) 10, 10, 6 Hz, 1 H), 3.76-3.68 (dd, J ) 11,
7 Hz, 1 H), 3.66-3.63 (m, 2 H), 2.83-2.72 (ddd, J ) 10, 6, 3
Hz, 1 H), 2.58-2.48 (ddd, J ) 13, 6, 6 Hz, 1 H), 2.40-2.25
(ddd, J ) 13, 12, 12 Hz, 1 H), 2.36-2.28 (ddd, J ) 13, 9, 7 Hz,
1 H), 0.90 (s, 9 H), 0.09 (s, 3 H), 0.05 (s, 3H). 13C NMR (67.9
MHz, CDCl3) δ 168.3 (s), 140.0 (s), 128.7 (s), 128.0 (s), 127.0
(s), 68.3 (d), 63.4 (d), 54.4 (t), 49.4 (d), 47.5 (d), 42.5 (t), 41.9
(t), 25.7 (q), 24.0 (d), 17.9 (s), -4.9 (q). IR (KBr) 2956 (s), 2928
(s), 1640 (s, CO), 1252 (m) cm-1. MS (70 eV, EI, 160 °C) m/z
425 (0.18) [M+], 424 (0.27) [M+ - H], 410 (4.17) [M+ - CH3],
368 (100) [M+ - C4H9]. HRMS calcd for C19H27NO2 79Br Si
408.09945 (M+ - CH3), found 408.09965 (M+ - CH3).
2R ,6R ,8R ,8a S -6-Be n zyloxy-2-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-p h en ylsela n yl-5(8H)-in d olizid in on e 10c. Reac-
tion of azoninone 5a (960 mg, 2.06 mmol) and PhSeBr
following the standard procedure B. Purification by column
chromatography on silica gel (hexane/EtOAc 2:1, Rf ) 0.28).
Yield: indolizidinone 10c (820 mg, 74%) as colorless needles,
mp 77 °C (recrystallization from Et2O/hexane). [R]20 2.1 (c )
D
1.9, CHCl3). 1H NMR (270 MHz, CDCl3) δ 7.60-7.50 (m, 2 H),
7.4-7.1 (m, 8 H), 4.90-4.85 (d, J ) 12 Hz, 1 H), 4.73-4.67 (d,
J ) 12 Hz, 1 H), 4.40-4.35 (dd, J ) 5, 5 Hz, 1 H), 3.85-3.80
(dd, J ) 4, 2 Hz, 1 H), 3.80-3.67 (m, 2 H), 3.78-3.73 (dd, J )
5, 2 Hz, 1 H), 3.37 -3.30 (d, J ) 13 Hz, 1 H), 3.32-3.20 (ddd,
J ) 13, 11, 4 Hz, 1 H), 2.50-2.40 (ddd, J ) 14, 3, 3 Hz, 1 H),
2.25-2.18 (dd, J ) 13, 4 Hz, 1 H), 1.98-1.85 (ddd, J ) 14, 13,
4 Hz, 1 H), 1.60-1.49 (ddd, J ) 12, 12, 4 Hz, 1 H), 0.80 (s, 9
H), 0.05 (s, 3 H), 0.01 (s, 3 H). 13C NMR (67.9 MHz, CDCl3) δ
166.6 (s), 138.1 (d), 136.1 (d), 129.1 (d), 128.4 (d), 128.2 (d),
127.8 (d), 127.5 (d), 125.9 (d), 73.9 (d), 72.8 (t, C-10), 68.1 (d),
61.6 (d), 55.4 (t), 42.7 (t), 37.2 (t), 37.1 (d), 25.7 (q), 17.9 (s),
-4.8 (q), -4.9 (q). IR (KBr) 2952 (s), 2883 (s), 1635 (s, CO),
1253 (s) cm-1. MS (80 eV, EI, 180 °C): m/z 531 (0.5) [M+], 516
(2.9) [M+ - CH3], 474 (90) [M+ - C4H9], 425 (45) [M+ - CH3
- Bn]. HRMS: calcd for C26H34NO3SeSi: 516.14731 (M+ - CH3
), found 516.14719 (M+ - CH3).
2R,6S,8R,8a S-8-Br om o-2-(ter t-bu tyld im eth ylsilyloxy)-
6-p h en yl-5(8H)-in d olizid in on e 9c: Reaction of azoninone 4a
(0.2 g, 0.45 mmol) and Br2 following the standard procedure
B. Purification by column chromatography on silica gel (hex-
ane/EtOAc 3:1, Rf ) 0.25). Yield: indolizidinone 9a /c (107 mg,
55%, ratio 1:4) as a colorless oil. Separation of 9a and 9c via
HPLC. [R]20 -28.3 (c ) 1.9, CHCl3). 1H NMR (270 MHz,
D
CDCl3) δ 7.40-7.25 (m, 3 H), 7.10-7.00 (m, 2 H), 4.48-4.43
(dd, J ) 4, 4 Hz, 1 H), 4.13-4.03 (ddd, J ) 11, 11, 4 Hz, 1 H),
3.95-3.88 (dd, J ) 13, 5 Hz, 1 H), 3.95-3.85 (m, 2 H), 3.58-
3.50 (d, J ) 14 Hz, 1 H), 2.73-2.60 (ddd, J ) 14, 14, 7 Hz, 1
H), 2.56-2.46 (ddd, J ) 14, 4, 2 Hz, 1 H), 2.36-2.28 (dd, J )
13, 5 Hz, 1 H), 1.75-1.62 (ddd, J ) 12, 12, 4 Hz, 1 H), 0.90 (s,
9 H), 0.09 (s, 3 H), 0.05 (s, 3 H). 13C NMR (67.9 MHz, CDCl3)
δ 168.1 (s), 141.1(s), 128.7 (d), 127.8 (d), 126.9 (d), 68.0 (d),
63.2 (d), 56.3 (t), 47.8 (d), 44.7 (d), 42.9 (t), 41.3 (t), 25.7 (q),
17.9 (s), -4.8 (q), -4.9 (q). IR (KBr) 2959 (s), 2883 (s), 2858
(s), 1645 (s, CO), 1257 (s) cm-1. MS (80 eV, EI, 130 °C) m/z
424 (0.45) [M+], 423 (0.2) [M+ - H], 408 (4.1) [M+ - CH3],
368 (100) [M+ - C4H9]. HRMS: calcd for C19H2779BrNO2Si:
408.09945 (M+ - CH3 ), found 408.09925 (M+ - CH3).
2R ,6R ,8R ,8a S-2-Be n zyloxy-6-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-iod o-3-(8H)-in d olizid in on e 11a . Reaction of azon-
inone 5a (31 mg, 0.07 mmol) and I2 following the standard
procedure A. Purification by column chromatography on silica
gel (hexane/EtOAc 3:1, Rf ) 0.45). Yield: indolizidinone 11a /c
(12 mg, 36%, ratio 1:3) as a colorless oil. Separation of 11a
and 11c via HPLC. [R]20D -10° (c ) 0.3, CHCl3). 1H NMR (270
MHz, CDCl3) δ 7.4-7.2 (m, 5 H), 4.94-4.88 (d, J ) 12 Hz, 1
H), 4.74-4.66 (d, J ) 12 Hz, 1 H), 4.14-4.05 (m, 2 H), 4.03-
3.93 (ddd, J ) 12, 11, 4 Hz, 1 H), 3.90-3.85 (m, 1 H), 3.85-
3.75 (ddd, J ) 11, 7, 6 Hz, 1 H), 2.90-2.83 (dd, J ) 15, 2 Hz,
1 H), 2.51-2.42 (dddd, J ) 14, 6, 6, 3 Hz, 1 H), 2.41-2.30
(ddd, J ) 11, 7, 3 Hz, 1 H), 2.21-2.10 (m, 1 H), 2.09-1.98
(ddd, J ) 14, 8, 5 Hz, 1 H), 0.80 (s, 9 H), 0.05 (s, 3 H), 0.01 (s,
3 H). 13C NMR (62.9 MHz, CDCl3) δ 172.1, 137.7, 128.4, 128.0,
127.7, 74.5, 72.0, 67.0, 61.7, 46.1, 45.2, 34.2, 27.6, 25.6, -4.9,
-5.0. IR (KBr) 2952 (s), 2927 (s), 1700 (s), 1258 (m) cm-1. MS
2R ,6R ,8R ,8a S -2-Be n zyloxy-6-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-p h en ylsela n yl-3-(8H)-in d olizid in on e 10a . Reac-
tion of azoninone 5a (100 mg, 0.21 mmol) and PhSeBr
following the standard procedure A. Purification by column
chromatography on silica gel (hexane/EtOAc 5:1, Rf ) 0.31).
Yield: indolizidinone 10a /c (52 mg, 46%, ratio 5:1) as a
colorless oil. Separation of 10a and 10c via HPLC. [R]20D -18.3
1
(c ) 1.1, CHCl3). H NMR (270 MHz, CDCl3) δ 7.6 (m, 2 H),
7.4-7.2 (m, 8 H), 4.94-4.88 (d, J ) 12 Hz, 1 H), 4.74-4.66 (d,
J ) 12 Hz, 1 H), 4.10-4.03 (dd, J ) 8, 4 Hz, 1 H), 4.02-3.95
(m, 2 H), 3.53-3.42 (ddd, J ) 11, 7, 6 Hz, 1 H), 3.18-3.07
(ddd, J ) 12, 11, 4 Hz, 1 H), 2.73-2.65 (dd, J ) 15, 2 Hz, 1
H), 2.40-2.28 (ddd, J ) 11, 7, 3 Hz, 1 H), 2.25-2.15 (dddd, J
) 14, 6, 6, 3 Hz, 1 H), 2.15-2.05 (ddd, J ) 14, 8, 5 Hz, 1 H),
1.70-1.60 (m, 1 H), 0.80 (s, 9 H), 0.05 (s, 3 H), 0.01 (s, 3 H).
13C NMR (62.9 MHz, CDCl3) δ 171.8, 137.9, 135.8, 129.1, 128.3,
128.2, 128.0, 127.6, 126.4, 71.9, 65.6, 59.0, 45.9, 41.6, 40.0, 33.2,
25.6, 17.9, -4.9, -5.16. IR (KBr) 2953 (s), 2927 (s), 1699 (s,
CO), 1258 (m) cm-1. MS (80 eV, EI, 160 °C) m/z 516 (2.9) [M+
- CH3], 474 (100) [M+ - C4H9], 425 (45) [M+ - CH3 - Bn].
HRMS calcd for C26H34NO3SiSe: 516.14732 (M+ - CH3 ), found
516.14337 (M+ - CH3).
(70 eV, EI, 130 °C): m/z 500 (0.2) [M - H+ ], 486 (4) [M+
CH3], 444 (35) [M+ - C4H9], 395 (72) [M+ - C7H7 - CH3].
-
2R ,6R ,8S ,8a R -2-Be n zyloxy-6-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-iod o-5(8H)-in d olizid in on e 11b. Reaction of azoni-
none 5b (130 mg, 0.28 mmol) with I2 following the standard
procedure B. Purification by column chromatography on silica
gel (hexane/EtOAc 7:1, Rf ) 0.4). Yield: indolizidinone 11b
(55.2 mg, 40%) as a colorless oil. [R]20 77.1 (c ) 1.8, CHCl3).
D
1H NMR (270 MHz, CDCl3) δ 7.4-7.1 (m, 5 H), 4.95-4.88 (d,
J ) 12 Hz, 1 H), 4.78-4.73 (d, J ) 12 Hz, 1 H), 4.40-4.30 (m,
1 H), 4.00-3.80 (m, 3 H), 3.65-3.55 (m, 2 H), 2.88-2.78 (ddd,
J ) 11, 7, 5 Hz, 1 H), 2.55-2.40 (m, 2 H), 1.95-1.75 (m, 1 H),
0.80 (s, 9 H), 0.05 (s, 3 H), 0.01 (s, 3 H). 13C NMR (62.9 MHz,
CDCl3) δ 167.8 (s), 137.7, 128.3, 127.9, 127.7, 74.9 (d), 72.7
(t), 68.1(d), 61.4 (d), 54.3 (t), 43.1 (t), 41.8 (t), 21.8 (d), 25.7
(q), 17.9 (s), -4.8 (q). IR (KBr) 2976 (s), 2926 (s), 1641 (s, CO),
1257 (m) cm-1. MS (80 eV, EI, 150 °C) m/z 500 (0.2) [M - H+],
2R ,6R ,8S ,8a R -2-Be n zyloxy-6-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-p h en ylsela n yl-5(8H)-in d olizid in on e 10b. Reac-
tion of azoninone 5b (13 mg, 0.03 mmol) and PhSeBr following
the standard procedure B. Purification by column chromatog-
raphy on silica gel (hexane/EtOAc 7:1, Rf ) 0.38). Yield:
indolizidinone 10b (3.5 mg, 20%) as a colorless oil. [R]20 73.2
D
(c ) 2, CHCl3). H NMR (270 MHz, CDCl3) δ 7.60-7.50 (m, 2
486 (4) [M+ - CH3], 444 (100) [M+ - C4H9], 395 (84) [M+
-
1
H), 7.40-7.20 (m, 8 H), 4.95-4.85 (d, J ) 12 Hz, 1 H), 4.75-
4.65 (d, J ) 12 Hz, 1 H), 4.38-4.28 (m, 1 H), 3.98-3.80 (dd, J
) 8, 7 Hz, 1 H), 3.70-3.55 (ddd, J ) 10, 10, 6 Hz, 1 H), 3.56-
3.50 (dd, J ) 12, 6 Hz, 1 H), 3.50-3.43 (dd, J ) 12, 5 Hz, 1 H),
3.10-3.00 (ddd, J ) 11, 11, 5 Hz, 1 H), 2.58-2.48 (ddd, J )
11, 6, 4 Hz, 1 H), 2.45-2.35 (ddd, J ) 12, 6, 6 Hz, 1 H), 2.08-
1.95 (ddd, J ) 14, 12, 9 Hz, 1 H), 1.73-1.60 (ddd, J ) 13, 10,
7 Hz, 1 H), 0.80 (s, 9 H), 0.05 (s, 3 H), 0.01 (s, 3 H). 13C NMR
(62.9 MHz, CDCl3) δ 168.1 (s), 138.0, 136.0, 129.2, 128.5, 128.3,
C7H7 - CH3], 268 (51) [M+ - J -CH3 - C7H7]. HRMS calcd
for C20H29INO3Si: 486.09615 (M+ - CH3 ), found 486.09378
(M+ - CH3).
2R ,6R ,8R ,8a S -2-Be n zyloxy-6-(t er t -b u t yld im e t h ylsi-
lyloxy)-8-iod o-5(8H)-in d olizid in on e 11c. Reaction of azoni-
none 5a (100 mg, 0.21 mmol) and I2 following the standard
procedure B. Purification by column chromatography on silica
gel (hexane/EtOAc 3:1, Rf ) 0.31). Yield: indolizidinone 11c
(80 mg, 70%) as colorless needles, mp 99 °C (recrystallization